Standout Papers

Untangling the ErbB signalling network 1992 2026 2003 2014 5.4k
  1. Untangling the ErbB signalling network (2001)
    Yosef Yarden, Mark X. Sliwkowski Nature Reviews Molecular Cell Biology
  2. Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate (2008)
    Gail D. Lewis Phillips, Guangmin Li et al. Cancer Research
  3. Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor (2002)
    Jennifer L. Stamos, Mark X. Sliwkowski et al. Journal of Biological Chemistry
  4. Identification of Heregulin, a Specific Activator of p185 erbB2 (1992)
    William E. Holmes, Mark X. Sliwkowski et al. Science
  5. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex (2004)
    Matthew C. Franklin, Kendall D. Carey et al. Cancer Cell
  6. Treatment of HER2-positive breast cancer: current status and future perspectives (2011)
    Carlos L. Arteaga, Mark X. Sliwkowski et al. Nature Reviews Clinical Oncology
  7. An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors (2003)
    Antony W. Burgess, Hyun‐Soo Cho et al. Molecular Cell
  8. Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941 (2009)
    Teemu T. Junttila, Robert W. Akita et al. Cancer Cell
  9. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. (1994)
    Mark X. Sliwkowski, Gabriele Schaefer et al. Journal of Biological Chemistry
  10. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers (1999)
    Mark D. Pegram, Gail D. Lewis Phillips et al. Oncogene
  11. Antibody Therapeutics in Cancer (2013)
    Mark X. Sliwkowski, Ira Mellman Science

Immediate Impact

6 by Nobel laureates 41 from Science/Nature 168 standout
Sub-graph 1 of 15

Citing Papers

Deciphering breast cancer: from biology to the clinic
2023 Standout
Peptide-Based Vaccines: Current Progress and Future Challenges
2019 Standout
34 intermediate papers

Works of Mark X. Sliwkowski being referenced

Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
2004 Standout
Untangling the ErbB signalling network
2001 Standout
and 25 more

Author Peers

Author Last Decade Papers Cites
Mark X. Sliwkowski 14288 9663 9750 110 21.5k
Nancy E. Hynes 10336 4872 10660 201 18.7k
Steven Wong 11375 6484 6542 35 15.8k
Dihua Yu 8892 2824 10663 238 18.5k
Michael F. Press 19794 8968 9503 222 29.9k
Michael J. Eck 12335 2198 18019 156 32.0k
Patricia S. Steeg 8285 1347 13074 198 22.7k
David F. Stern 5742 2852 7544 139 12.5k
Federico Rojo 7491 1824 6966 263 13.2k
William J. Muller 9110 1915 13130 264 20.9k
Jeffrey Settleman 10236 938 13871 158 23.2k

All Works

Loading papers...

Rankless by CCL
2026